AMGN earnings: real EPS beat/miss history, analyst consensus Buy, P/E 25.28. Updated 2026-07-23.
Amgen (AMGN) Research Hub
Amgen (AMGN) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - General) sector. As of 2026-09-11, shares last closed at 377.35 USD (-3.56%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 25.28, market cap 198.21B. This hub links to the full technical, earnings and options research available for AMGN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - General) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 377.35 USD (-3.56%) |
| 52-week range | 337.6 USD – 447.03 USD |
| Trend regime | Range |
| 14-day RSI | 36.6 (Bearish) |
| Trailing P/E | 25.28 |
| Market cap | 198.21B |
| Dividend yield | 2.68% |
Available research for AMGN
Covered Call on AMGN: how it works, illustrative setup around the real 377.35 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on AMGN: how it works, illustrative setup around the real 377.35 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on AMGN: how it works, illustrative setup around the real 377.35 USD price, max profit/loss, breakeven and when to use it. Educational.
AMGN technical analysis: range, last 377.35 USD, RSI 36.6, 52w range 337.6 USD–447.03 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is AMGN in?
Amgen (AMGN) is classified under Healthcare (Drug Manufacturers - General), listed on NASDAQ, US.
Is AMGN in an uptrend or downtrend?
As of 2026-09-11, AMGN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is AMGN's trailing P/E ratio?
AMGN's trailing P/E is 25.28, with a market cap of 198.21B. See the earnings research page for full valuation detail.